Grace Wade is a health reporter at New Scientist. She focuses on public health, nutrition, and biotechnology, bringing a keen understanding of health and wellness to her reporting. Grace has been featured in Knowledia, New Scientist, and the Daily Mail.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Not enough data
Grace Wade's coverage predominantly focuses on healthcare, pharmaceuticals, and scientific advancements. She frequently cites data in her articles, indicating a preference for evidence-based information.
Given the nature of her article titles and themes covered, Grace may be interested in pitches that offer access to experts involved in medical research or drug development related to mental health, neurology, and Covid-19. Offering access to new studies or clinical trials could also attract her attention.
Remember not to limit your outreach based on geographic focus as Grace's coverage does not seem restricted by location.
This information evolves through artificial intelligence and human feedback. Improve this profile .
After starting the year with its first known bird flu death, the US expanded its efforts to contain the virus, which enabled it to end its public health emergency response months later
An experimental gene therapy seems to slow the progression of Huntington’s disease by about 75 per cent, and researchers are working to make its complicated delivery much more practical
The US government is approving the drug leucovorin to address rising rates of autism, despite limited evidence that it works.
After finding success with last year's New Year's resolution, health reporter Grace Wade has grand plans for 2026 – and the science to back them up
The protein craze is in full swing and beef consumption is on the rise, particularly in the US, where health agencies are promoting red meat as part of an optimum diet.
The books, TV, games and more that New Scientist staff have enjoyed this week
One-third of people with anorexia nervosa don’t recover and treatment has remained stagnant for years. Now we’re beginning to understand how the condition takes over the mind
The brain undergoes a full renovation during menopause. Although these changes are profound, we’re learning that the long-term impact needn’t be all bad
A drug advisory committee in the US has recommended approval for several experimental peptides. But there have been no large-scale tests of these new compounds in humans, finds columnist Grace Wade
The wellness boom has brought a wide array of consumer products that promise to boost your health and happiness. Xand van Tulleken has delved into it all and explains how to think about the evidence behind the hype
